Form 4 filings across 2 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$241K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
2 of 6 filings we hold were filed after the two-business-day deadline. The furthest past the deadline was 5 business days late.
The 8 most recent Form 4 transactions.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
| Aug 3 | HEPA | Hepion Pharmaceuticals,… | PBUY | 2M | $0.05 | $100K | +160.0% | Open the original filing on SEC.gov |
| Apr 21 | HEPA | Hepion Pharmaceuticals,… | PBUY | 1.3M | $0.04 | $50K | — | Open the original filing on SEC.gov |
| Nov 3, 2025 | THAR | Tharimmune, Inc. | AGRANT◆ | 20,000 | — | — | — | Open the original filing on SEC.gov |
| Aug 4, 2025 | THAR | Tharimmune, Inc. | AGRANT◆ | 90,000 | — | — | — | Open the original filing on SEC.gov |
| Jun 20, 2025 | THAR | Tharimmune, Inc. | PBUY | 690 | $1.42 | $980 | +1.1% | Open the original filing on SEC.gov |
| Jun 20, 2025 | THAR | Tharimmune, Inc. | PBUY | 60,806 | $1.48 | $90K | +1,803% | Open the original filing on SEC.gov |